Golden Sun Health Technology Group Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Golden Sun Health Technology Group Limited (GSUN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Sep 2023Sep 2022Sep 2021Sep 2020
Operating Activities
Net Income-3.97-5.79-2.141.980.04
Depreciation & Amortization0.480.480.170.140.09
Deferred Income Tax0.000.000.000.020.00
Stock Based Compensation0.001.830.000.000.00
Change in Working Capital-2.55-0.812.69-2.360.50
Change in Accounts Receivable-0.130.230.54-1.22-0.16
Change in Inventory-0.33-0.160.000.000.00
Change in Accounts Payable0.390.341.021.050.00
Change in Other Working Capital-2.47-1.002.56-1.09-0.87
Other Operating Activities1.140.010.02-0.65-0.17
Net Cash from Operating Activities-4.90-4.220.910.031.51
Investing Activities
Capital Expenditures-0.13-3.97-0.17-0.09-0.32
Acquisitions-1.73-3.730.000.000.00
Purchases of Investments0.00-5.450.000.000.00
Sales/Maturities of Investments0.00-0.030.000.000.00
Other Investing Activities-0.110.000.00-0.12-1.26
Net Cash from Investing Activities-1.97-9.45-0.17-0.21-1.58
Financing Activities
Debt Repayment0.35-7.74-1.35-2.15-1.91
Common Stock Issued0.000.0018.280.000.00
Other Financing Activities0.770.17-0.924.93-0.06
Net Cash from Financing Activities1.120.2518.63-2.000.02
Summary
Effect of Forex Changes on Cash0.04-0.37-0.220.170.00
Net Change in Cash-5.71-13.7919.37-2.18-1.96
Cash at Beginning of Period6.5520.351.193.210.00
Cash at End of Period0.846.5520.351.190.00
Free Cash Flow-5.03-8.190.74-0.061.19
Supplemental Disclosures
Interest Paid0.270.350.220.140.11
Income Taxes Paid0.010.000.000.010.00